Best Medical Stocks To Follow Today – February 09th

Eli Lilly and Company, UnitedHealth Group, and Merck & Co., Inc. are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are securities issued by companies within the healthcare industry, including pharmaceutical, biotechnology, medical device, and healthcare service providers. Investors can purchase these stocks to gain exposure to the healthcare sector and potentially benefit from the growth and performance of these companies. Factors that can impact medical stocks include drug approvals, clinical trial results, regulatory changes, and healthcare market trends. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

LLY stock traded up $7.72 during mid-day trading on Friday, hitting $878.09. The company had a trading volume of 4,421,566 shares, compared to its average volume of 4,056,943. The company has a market capitalization of $833.59 billion, a price-to-earnings ratio of 74.99, a P/E/G ratio of 1.87 and a beta of 0.42. The company has a 50-day moving average price of $789.87 and a 200 day moving average price of $843.31. The company has a quick ratio of 0.97, a current ratio of 1.27 and a debt-to-equity ratio of 2.03. Eli Lilly and Company has a 12-month low of $711.40 and a 12-month high of $972.53.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

NYSE UNH traded down $3.36 during trading on Friday, hitting $526.68. 3,344,880 shares of the stock traded hands, compared to its average volume of 4,348,924. The firm has a 50-day simple moving average of $529.18 and a 200-day simple moving average of $564.37. UnitedHealth Group has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $484.69 billion, a P/E ratio of 33.98, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

Shares of NYSE MRK traded down $0.79 during mid-day trading on Friday, hitting $87.26. 15,806,931 shares of the company’s stock traded hands, compared to its average volume of 14,162,434. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.36 and a quick ratio of 1.15. Merck & Co., Inc. has a 1 year low of $87.12 and a 1 year high of $134.63. The company’s 50-day moving average is $98.72 and its two-hundred day moving average is $106.48. The company has a market capitalization of $220.73 billion, a P/E ratio of 12.97, a PEG ratio of 0.83 and a beta of 0.38.